Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elk Bioscience, officially known as Wuhan Elk Science & Technology Co., Ltd., is a biotechnology company based in Wuhan, China, specializing in the development and production of life science research reagents. The company offers an extensive portfolio of over 10,000 ELISA kits, 12,000 antibodies, and a wide range of molecular biology products and recombinant proteins. Their products support research across diverse fields including oncology, immunology, neuroscience, and cell biology, serving academic and pharmaceutical researchers globally. Elk Bioscience maintains rigorous quality control standards, including ISO 9001:2015 certification, to ensure the reliability and reproducibility of their research tools. The company operates primarily as a manufacturer and supplier, providing high-quality validated reagents to facilitate scientific discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elk Bioscience.